Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
about
Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report.Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in rats.Pituitary-Directed Therapies for Cushing's Disease.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
@ast
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
@en
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
@nl
type
label
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
@ast
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
@en
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
@nl
prefLabel
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
@ast
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
@en
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
@nl
P2860
P921
P3181
P1433
P1476
Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly
@en
P2093
Julie M. Silverstein
P2860
P2888
P304
P3181
P356
10.1007/S11102-016-0734-1
P407
P5008
P577
2016-10-01T00:00:00Z